Compounds > n-(2-chloroethyl)-4-piperidinyl diphenylacetate
Page last updated: 2024-09-03

n-(2-chloroethyl)-4-piperidinyl diphenylacetate and 4-fluorohexahydrosiladifenidol

n-(2-chloroethyl)-4-piperidinyl diphenylacetate has been researched along with 4-fluorohexahydrosiladifenidol in 1 studies

Compound Research Comparison

Studies
(n-(2-chloroethyl)-4-piperidinyl diphenylacetate)		Trials
(n-(2-chloroethyl)-4-piperidinyl diphenylacetate)		Recent Studies (post-2010)
(n-(2-chloroethyl)-4-piperidinyl diphenylacetate)		Studies
(4-fluorohexahydrosiladifenidol)		Trials
(4-fluorohexahydrosiladifenidol)		Recent Studies (post-2010) (4-fluorohexahydrosiladifenidol)
270382010

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eglen, RM; Harris, GC1

Other Studies

1 other study(ies) available for n-(2-chloroethyl)-4-piperidinyl diphenylacetate and 4-fluorohexahydrosiladifenidol

ArticleYear
Selective inactivation of muscarinic M2 and M3 receptors in guinea-pig ileum and atria in vitro.
    British journal of pharmacology, 1993, Volume: 109, Issue:4

    Topics: Alkylating Agents; Animals; Atropine; Diamines; Dioxolanes; Diphenylacetic Acids; Guinea Pigs; Heart; Heart Atria; Ileum; In Vitro Techniques; Isometric Contraction; Male; Muscarinic Antagonists; Muscle, Smooth; Parasympatholytics; Phenoxybenzamine; Pilocarpine; Piperidines; Receptors, Muscarinic

1993